Latest Options Offer News

Taiton Resources has raised $1.25 million through a discounted placement to accelerate drilling at its Highway Copper-Gold Project, including immediate work on the high-priority Yogi IOCG target, alongside exploration at Challenger West and technical studies at Kingsgate.

European Resources Limited (ASX: ERE) has repriced and relaunched a renounceable rights issue to raise up to $3.4 million, partially underwritten by Mahe Capital for $1.5 million, to fund metallurgical and exploration work at its Korsnäs rare earth project in Finland and Slovakian tenements.

Novo Resources has officially listed over 25 million free-attaching options on the ASX, following its recent capital raising. These options, exercisable at 15 cents, underpin the company’s ongoing exploration ambitions across Western Australia and New South Wales.

European Resources Limited (ASX: ERE) has announced a $4.26 million renounceable entitlement offer to accelerate exploration and metallurgical work at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, providing shareholders with a strategic opportunity amid significant recent resource growth.

Imugene Limited has launched a $20 million capital raising through a $12 million institutional placement and an $8 million Share Purchase Plan, alongside a convertible notes amendment to support its clinical development pipeline.

Novo Resources Corp. has issued a prospectus offering free New Options to recent placement participants and joint lead managers, aiming to support its exploration projects in Western Australia and Victoria. The options, exercisable at A$0.15 and expiring in three years, could raise significant capital upon exercise, subject to shareholder approval.

3D Energi Limited has offered 41.7 million free attaching options to investors from its October 2025 Placement, aiming to clear trading restrictions despite ongoing ASX suspension and financial challenges.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Galilee Energy has launched an offer of up to 464 million new options to participants in its recent $6.5 million placement, aiming to bolster exploration funding and working capital. The options, exercisable at $0.011 each over three years, come amid significant operational and market risks.

US1 Critical Minerals has provided clarity on the issuance of 50 million fee options to consultants related to its December 2025 placement, reaffirming shareholder approval is pending and no funds will be raised from this issuance.

Talga Group has lodged a detailed prospectus for issuing attaching and piggyback options to recent Placement and Share Purchase Plan participants, potentially raising up to A$32.7 million upon exercise. The move supports its battery anode production scale-up and international expansion plans.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.